Post-Heart Transplant Hypertension and Conditional Survival
Hypertension (HTN) is common after orthotopic heart transplant (OHT) and is associated with cardiac allograft vasculopathy (CAV), which is strongly related to mortality. Few data are available regarding whether anti-HTN medications in OHT patients who develop HTN will reduce mortality or incidence of CAV. Our goal was to determine if specific anti-HTN medications were associated with a reduction in CAV or were associated with survival.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Lu Chen, Mohamed Derbala, Edvard Gumbs, Aaron Guo, Sakima Smith Tags: 451 Source Type: research
More News: Bone Graft | Cardiology | Heart | Heart Transplant | Hypertension | Transplant Surgery | Transplants